News:
LA3. Pepscan Technology for Fighting Cancer
The idea that the immune system can recognize and respond to tumors was formed in the late 19th century when William Coley, a surgeon at the Memori...
» more
|
|
|
News:
JO 080827: Postdoctoral position
|
|
A postdoctoral position to work on structural and biochemical aspects of ubiquitin-mediated signalling events is available in the laboratory of Dr....
» more
|
|
|
News:
C1a: 2008, September 12-18, EMBO Course: Ubiqui...
|
|
The objective of this course is to teach a wide range of state of the art methods for the in vitro and in vivo functional analysis of ubiquitylatio...
» more
|
|
|
News:
JO 080828: Independent group leader position
|
|
The Department of Molecular Cell Biology of the Max Planck Institute of Biochemistry (Martinsried/Munich, Germany) invites applications for an inde...
» more
|
|
|
Participant:
Matthias Mann's Group
|
|
The department of proteomics and signal transduction, led by Prof. Matthias Mann, was established in July 2005 and is currently comprised of 30 peo...
» more
|
|
|
Participant:
Ger Strous's Group
|
|
Our major aim is to elucidate the molecular mechanisms that determine the Growth Hormone (GH) sensitivity of cells. Cells of the human body contain...
» more
|
|
|
Participant:
Stefan Jentsch's Group
|
|
The Max Planck Institute of Biochemistry offers outstanding research and training opportunities and has an exceptional strength at molecular, cell,...
» more
|
|
|
Participant:
CYTOMICS SYSTEMS
CYTOMICS SYSTEMS’ protein degradation approach to drug discovery relies on UbiScreen®, a patented functional screening technology relevant to all t...
» more
|
|
|
Participant:
Pascal Genschik's Group
|
|
Pascal Genschik, is currently the Scientific Director of the Institut de Biologie Moléculaire des Plantes du CNRS. In the past, he was studying nuc...
» more
|
|
|
Participant:
Alain Israël's Group
The group focuses on the analysis of two signaling pathways : NF-kappaB and Notch. More specifically, ex vivo approaches based on biochemical and g...
» more
|
|
